Displaying items 13-24 of 49
» View herald-mail.com items only
< Previous
•
1
2
3
4
5
•
Next >
-
Inaugural fundraisers race to meet $50-million goal
WASHINGTON — With less than a week to go before President Obama is sworn in for his second term, fundraisers for the presidential inaugural committee were still working Monday to secure their goal of $50 million in private donations to finance the...
Tags: Economy, Business and Finance, Centene Corporation, Federal Election Commission, Silver Spring (Montgomery, Maryland), Arts and Culture
-
CDC: Flu season `bad one for the elderly'
The number of older people hospitalized with the flu has risen sharply, prompting federal officials to take unusual steps to make more flu medicines available and to urge wider use of them as soon as symptoms appear. The U.S. is about halfway through...Tags: Viral Diseases and Infections, Margaret Hamburg, Food and Drug Administration, Flu, Pneumonia
-
Other Voices
While the U.S. economy as a whole remains sluggish, the farm sector has been doing well. Exceptionally well, in fact. Last year, net farm income was a record $101 billion, and it's expected to be only slightly off the pace in 2012. With the national...Tags: Fannie Mae, Public Finance, Pat Roberts, National Institutes of Health, China
-
New Avastin tests add to confusion over use in breast cancer
In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...Tags: Heart Failure, Human Body, Richmond (Richmond, Virginia), Heart Attack, Medical Procedures and Tests
-
Roche won't extend $6.8 billion bid for San Diego's Illumina
Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members. Roche’s current offer of $51 per Illumina...
Tags: Economy, Business and Finance, Companies and Corporations, Shareholders, Genes and Chromosomes, Diabetes
-
|Story
-
Big promise is seen in 2 new breast cancer drugs
SAN ANTONIO (AP) — Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
In a large international...Tags: Herceptin (drug), Hospitals and Clinics, Food and Drug Administration, Heart Problems, Novartis AG
-
New help for basal cell skin cancer patients
HealthOn Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell... -
Steve Jobs Refused Surgery That Could Have Saved Him
Reuters/KTLA NewsLOS ANGELES (KTLA) -- Apple Inc co-founder Steve Jobs refused potentially life-saving cancer surgery for nine months, shrugging off protests from his family and opting instead for alternative medicine, according to the tech visionary's biographer. When...Tags: Exxon Mobil Corporation, Mergers, Acquisitions and Takeovers, Health and Safety at Work, Fine Arts, Government
-
Disney CEO Iger joins Apple board; Levinson named chairman
TechnologyIn the first change to Apple's boardroom since the death of Steve Jobs last month, the company announced that Walt Disney Co. President and Chief Executive Robert Iger will be the Cupertino electronics maker's newest board member.... -
Cancer-fighting pill shows promise in battle against melanoma
MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer.
A local oncologist says drug is not a cure, but it shrank tumors and patients who used the drug lived longer....Tags: Medical Specialization, Oncology, Food and Drug Administration, Human Body, Science and Technology
-
Avastin: There's the truth and then there's the politics behind the cancer drug [The conversation]
Opinion L.A.Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
Jan 14, 2013
|Story| Los Angeles Times
Jan 18, 2013
|Story| Aberdeen News
May 25, 2012
|Story| Aberdeen News
Jan 30, 2012
|Story| Los Angeles Times
Apr 18, 2012
|Story| Los Angeles Times
Feb 1, 2012
|Story| Los Angeles Times
Dec 7, 2011
|Story| Petoskey News
Feb 1, 2012
| Allentown Morning Call
Oct 20, 2011
|Story| KTLA-LTV
Nov 15, 2011
| Los Angeles Times
Jun 6, 2011
|Story| WSBT-TV
Jun 28, 2011
| Los Angeles Times
Original site for Genentech Inc. topic gallery.
